SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 013

1. Describe the main pathologic characteristics of diffuse interstitial lung disease and classify it according to etiology.

Diffuse interstitial lung diseases are characterized by chronic inflammation and fibrosis involving the pulmonary interstitium and alveolar walls. They reduce lung compliance and impair gas exchange. Histologically, there is varying degrees of interstitial inflammation, fibroblast proliferation, and collagen deposition.

Advanced disease results in honeycomb lung due to cystic fibrotic spaces. Etiologically, they are classified into idiopathic interstitial pneumonias, occupational lung diseases, drug-induced lung disease, connective tissue disease-associated disorders, hypersensitivity pneumonitis, and granulomatous diseases such as sarcoidosis.

Idiopathic pulmonary fibrosis is the most common type. Progressive fibrosis causes restrictive lung disease.

Pulmonary hypertension may develop in advanced cases. Respiratory failure is the major cause of death.

2. What are the morphologic manifestations of diffuse interstitial disease of the lung?

The lungs become firm, stiff, and reduced in compliance because of widespread fibrosis. Gross examination shows diffuse scarring, particularly in the lower lobes in many forms of disease. Microscopically, the alveolar septa are thickened by chronic inflammatory cells and collagen deposition.

Fibroblast proliferation contributes to progressive fibrosis. Type II pneumocyte hyperplasia is often present during repair. Advanced disease produces honeycomb lung with multiple cystic airspaces lined by bronchiolar epithelium.

Pulmonary vessels may show medial hypertrophy due to pulmonary hypertension. Gas exchange is impaired because of increased diffusion distance.

Progressive fibrosis eventually causes respiratory insufficiency. The severity depends on the extent and duration of interstitial damage.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 011

1. What is the difference between bronchopneumonia and lobar pneumonia?

Bronchopneumonia is a patchy, multifocal bacterial infection centered on bronchioles and adjacent alveoli. It commonly affects infants, elderly individuals, and debilitated patients. Multiple foci of consolidation are scattered throughout one or more lobes, often involving both lungs.

Lobar pneumonia, in contrast, involves uniform consolidation of an entire lobe or a large portion of it. It is classically caused by Streptococcus pneumoniae. Bronchopneumonia is usually caused by organisms such as Staphylococcus aureus, Haemophilus influenzae, or gram-negative bacteria.

Lobar pneumonia progresses through well-defined pathological stages. Bronchopneumonia has a more irregular distribution and variable progression.

Both conditions impair gas exchange and may lead to respiratory failure if severe.

2. List the defense mechanisms that protect against bacterial pneumonia.

The respiratory tract possesses several defense mechanisms that prevent bacterial infection. The nasal passages filter inhaled particles. The mucociliary escalator removes microorganisms trapped in mucus. Cough and sneeze reflexes expel foreign material from the airways. Alveolar macrophages phagocytose inhaled bacteria reaching the alveoli.

Secretory IgA antibodies protect the respiratory mucosa. Complement proteins and neutrophils participate in bacterial killing. Surfactant proteins also contribute to innate immune defense. Normal respiratory flora inhibit colonization by pathogenic organisms.

Intact immunity and effective airway clearance are essential for preventing bacterial pneumonia.

3. Name the four classical stages of lobar pneumonia.

Lobar pneumonia classically progresses through four pathological stages. The first stage is congestion, occurring during the initial 24 hours, characterized by vascular engorgement and edema. The second stage is red hepatization, in which alveoli become filled with red blood cells, neutrophils, and fibrin, giving the lung a liver-like consistency.

The third stage is gray hepatization, during which red blood cells disintegrate while fibrin and leukocytes remain abundant. The fourth stage is resolution, where enzymatic digestion removes the exudate and normal lung architecture is restored.

Macrophages play a major role during resolution. Complete recovery usually occurs if treatment is prompt. Delayed resolution may lead to complications such as abscess formation or fibrosis.

4. Name the main pathologic characteristics of primary atypical pneumonia.

Primary atypical pneumonia is usually caused by viruses, Mycoplasma pneumoniae, Chlamydia, or other atypical organisms. The infection primarily affects the alveolar septa rather than filling alveolar spaces with exudate.

Grossly, the lungs show patchy areas of congestion without extensive consolidation. Microscopically, the interstitium contains mononuclear inflammatory cells, mainly lymphocytes and macrophages. The alveolar walls become thickened because of inflammatory infiltration.

Alveolar spaces contain little or no purulent exudate. Hyaline membranes may develop in severe viral infections.

Symptoms are often milder than in typical bacterial pneumonia despite widespread radiological changes. Most patients recover completely with appropriate treatment.

5. What are the most frequent conditions that predispose to the formation of pulmonary abscess?

Pulmonary abscess is a localized area of suppurative necrosis within the lung producing a cavity filled with pus. Aspiration of oropharyngeal secretions is the commonest predisposing factor, particularly in unconscious or alcoholic patients.

Necrotizing bacterial pneumonia may also lead to abscess formation. Bronchial obstruction caused by tumors or foreign bodies predisposes to secondary infection. Septic emboli from infective endocarditis can produce multiple lung abscesses. Tuberculosis and fungal infections occasionally result in cavitary lesions. Immunocompromised patients are at increased risk. Poor oral hygiene increases aspiration of anaerobic bacteria.

Untreated abscesses may rupture into the pleural cavity or bloodstream, causing serious complications.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 010

1. What is the meaning of the term bronchiectasis and how does it manifest clinically?

Bronchiectasis is the permanent abnormal dilatation of bronchi and bronchioles caused by destruction of the bronchial wall due to chronic infection and inflammation. It usually develops after repeated respiratory infections or bronchial obstruction.

 The damaged airways lose their elastic and muscular support. Patients present with chronic productive cough and large amounts of foul-smelling purulent sputum. Recurrent episodes of fever and chest infections are common.

Hemoptysis may occur due to erosion of bronchial blood vessels. Dyspnea and wheezing develop in advanced disease. Clubbing of fingers is seen in long-standing cases.

Pulmonary function gradually deteriorates if untreated. High-resolution CT is the investigation of choice for diagnosis.

2. What are the most frequent conditions associated with bronchiectasis?

 

Bronchiectasis commonly follows severe bacterial pneumonia, tuberculosis, or recurrent childhood respiratory infections. Bronchial obstruction by tumors, foreign bodies, or mucus plugs predisposes to localized bronchiectasis.

Congenital disorders such as cystic fibrosis are important causes. Primary ciliary dyskinesia, including Kartagener syndrome, impairs mucociliary clearance. Immunodeficiency disorders increase susceptibility to recurrent infections.

Allergic bronchopulmonary aspergillosis is another recognized cause. Chronic aspiration due to neurological disorders may contribute. Airway obstruction and persistent infection work together to destroy bronchial walls.

These conditions lead to irreversible bronchial dilatation. Early treatment of underlying diseases reduces the risk of bronchiectasis.

3. What is the triad of Kartagener syndrome?

 

Kartagener syndrome is a subtype of primary ciliary dyskinesia caused by inherited defects in ciliary structure and function. The classical triad consists of bronchiectasis, chronic sinusitis, and situs inversus. Defective ciliary movement prevents normal clearance of respiratory secretions. Recurrent respiratory infections lead to progressive bronchiectasis.

Chronic sinusitis causes persistent nasal congestion and discharge. Situs inversus results from abnormal embryonic organ rotation. Male infertility is common because sperm flagella are also immotile. Female fertility may also be reduced due to impaired fallopian tube ciliary function.

Diagnosis is confirmed by ciliary ultrastructural studies or genetic testing. Management focuses on preventing respiratory infections and preserving lung function.

4. Describe the major morphologic characteristics of bronchiectasis on gross inspection.

Grossly, the affected bronchi are permanently dilated and may extend almost to the pleural surface. The dilated bronchi contain thick purulent secretions.

The bronchial walls appear thickened, inflamed, and ulcerated. Depending on severity, the bronchi may be cylindrical, varicose, or cystic in appearance. Surrounding lung tissue often shows fibrosis and collapse.

The lower lobes are most commonly involved. Severe cases demonstrate multiple cyst-like dilatations filled with pus. Pleural fibrosis may accompany long-standing disease.

Microscopy reveals chronic inflammatory infiltrates and destruction of cartilage, smooth muscle, and elastic tissue. These irreversible structural changes account for persistent airway dysfunction.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 009

1. Define bronchial asthma and status asthmaticus.

Bronchial asthma is a chronic inflammatory disorder of the airways characterized by reversible bronchoconstriction, airway hyperresponsiveness, and increased mucus production.

Airflow obstruction is usually episodic and reversible either spontaneously or with treatment. Patients present with recurrent wheezing, cough, chest tightness, and breathlessness. Inflammation involves eosinophils, mast cells, lymphocytes, and airway epithelium.

Status asthmaticus is a severe, prolonged asthma attack that does not respond adequately to standard bronchodilator therapy. It causes persistent bronchospasm and severe airflow obstruction.

Patients develop profound hypoxemia and respiratory distress. Carbon dioxide retention indicates impending respiratory failure. Status asthmaticus is a medical emergency requiring immediate intensive treatment.

2. What are the main differences between extrinsic and intrinsic asthma?

Extrinsic asthma, also called atopic asthma, is mediated by IgE-dependent hypersensitivity reactions to environmental allergens. It commonly begins during childhood and is often associated with a personal or family history of allergy. Common allergens include pollen, dust mites, animal dander, and foods.

Intrinsic asthma is not associated with specific allergens or IgE-mediated reactions. It usually develops in adults after respiratory infections, stress, exercise, cold air, or exposure to irritants.

Skin allergy tests are positive in extrinsic asthma but usually negative in intrinsic asthma. Serum IgE levels are elevated in atopic asthma.

Both forms produce reversible airway obstruction and similar pathological changes. Clinical management is largely similar despite different initiating mechanisms.

3. What is the pathogenesis of atopic asthma?

Atopic asthma begins with sensitization to inhaled allergens in genetically susceptible individuals. Allergen exposure stimulates helper T lymphocytes to promote IgE production by B cells. IgE binds to mast cells present in the airway mucosa.

Re-exposure to the allergen causes cross-linking of IgE and mast cell degranulation. Histamine, leukotrienes, prostaglandins, and other mediators produce immediate bronchoconstriction. These mediators also increase vascular permeability and mucus secretion.

Eosinophils are recruited and release toxic proteins that damage airway epithelium. Chronic inflammation leads to airway remodeling with smooth muscle hypertrophy and subepithelial fibrosis.

Airway hyperresponsiveness persists even between acute attacks. The result is recurrent episodes of reversible airflow obstruction.

4. Describe the main differences between the acute and late-phase reactions in patients with bronchial asthma.

The acute phase begins within minutes after allergen exposure and is mediated primarily by mast cell degranulation. Histamine, leukotrienes, and prostaglandins cause immediate bronchospasm, edema, and mucus secretion.

Symptoms include sudden wheezing, cough, and breathlessness. The late-phase reaction develops approximately 4–8 hours later. It is characterized by infiltration of eosinophils, neutrophils, lymphocytes, and macrophages into the airway wall.

 These inflammatory cells release cytokines and toxic proteins that sustain airway inflammation. Airway edema and epithelial damage become more pronounced. Bronchial hyperresponsiveness increases during the late phase.

Repeated late-phase reactions contribute to chronic airway remodeling and persistent asthma.

5. What are the major mediators responsible for bronchospasm in patients with bronchial asthma?

Histamine released from mast cells is an important early mediator causing bronchoconstriction. Leukotrienes C4, D4, and E4 are among the most potent bronchoconstrictors and also increase vascular permeability. Prostaglandin D2 contributes to bronchospasm and vasodilation. Platelet-activating factor promotes inflammation and airway narrowing.

Cytokines such as IL-4, IL-5, and IL-13 stimulate IgE production and eosinophilic inflammation. Eosinophils release major basic protein and eosinophil cationic protein, damaging airway epithelium. Chemokines recruit additional inflammatory cells into the bronchi.

Acetylcholine released through parasympathetic pathways further enhances bronchoconstriction. Together these mediators produce airway hyperresponsiveness and recurrent asthma attacks.

6. What are the main pathologic characteristics of bronchial asthma?

The lungs are usually overexpanded because of air trapping during acute attacks. Bronchi and bronchioles are obstructed by thick mucus plugs. Mucus plugs contain Curschmann spirals and Charcot-Leyden crystals derived from eosinophils.

The bronchial mucosa is edematous and infiltrated by eosinophils, mast cells, and lymphocytes. Goblet cell hyperplasia causes excessive mucus production. The basement membrane becomes thickened because of subepithelial fibrosis. Smooth muscle hypertrophy contributes to airway narrowing.

Chronic inflammation produces airway remodelling and persistent hyperresponsiveness. Although airflow obstruction is usually reversible, long-standing disease may lead to partially irreversible changes.

These pathological findings explain the recurrent episodes of wheezing and dyspnea.

7. Discuss the clinical characteristics and prognosis of patients with bronchial asthma.

Bronchial asthma presents with recurrent episodes of wheezing, breathlessness, chest tightness, and cough, particularly at night or early morning. Symptoms are often triggered by allergens, exercise, infections, cold air, or irritants. Airflow obstruction is usually reversible with bronchodilator therapy. Pulmonary function tests demonstrate variable airflow limitation.

Most patients achieve good symptom control with inhaled corticosteroids and bronchodilators. Acute severe attacks may progress to status asthmaticus requiring emergency treatment. Repeated uncontrolled attacks can lead to airway remodeling and persistent airflow limitation.

Mortality is low with appropriate management but increases in severe uncontrolled asthma. Avoidance of triggers and adherence to long-term therapy significantly improve prognosis.

Early diagnosis and regular follow-up help maintain normal lung function and quality of life.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 008

1. Define the types of chronic bronchitis.

Chronic bronchitis is defined as a productive cough lasting for at least three months in each of two consecutive years after excluding other causes. Simple chronic bronchitis is characterized by chronic sputum production without significant airflow obstruction.

Chronic obstructive bronchitis is associated with persistent airflow limitation and forms part of COPD. Chronic asthmatic bronchitis combines chronic bronchitis with bronchial hyperresponsiveness. Smokers commonly develop chronic obstructive bronchitis.

Mucus gland enlargement and goblet cell hyperplasia are characteristic pathological features. Recurrent respiratory infections worsen airway inflammation.

 Progressive airflow limitation eventually develops in many patients. Chronic bronchitis remains a major preventable respiratory disease associated with tobacco smoking.

2. List the factors important for the pathogenesis of chronic bronchitis.

Chronic bronchitis develops mainly due to prolonged irritation of the bronchial mucosa by cigarette smoking, which is the most important risk factor. Air pollution, biomass fuel smoke, occupational dust, and chemical fumes also contribute. Recurrent respiratory infections aggravate airway inflammation but are usually secondary factors.

Chronic irritation causes hypertrophy of mucus glands and hyperplasia of goblet cells, resulting in excessive mucus secretion. Impaired ciliary function reduces mucociliary clearance and promotes mucus retention.

Persistent inflammation leads to edema, fibrosis, and narrowing of small airways. Airflow obstruction gradually develops and becomes irreversible. Repeated infections accelerate disease progression.

These changes ultimately produce chronic productive cough and progressive respiratory disability.

3. Discuss the pathologic characteristics of chronic bronchitis.

The bronchi are hyperemic, swollen, and filled with thick mucus. The bronchial mucosa shows chronic inflammation with infiltration by lymphocytes, macrophages, and plasma cells.

Hypertrophy of submucosal mucus glands is a characteristic feature. Goblet cell hyperplasia extends into the small bronchi and bronchioles. Excess mucus forms plugs that obstruct the airway lumen.

Chronic inflammation leads to fibrosis and thickening of the bronchial wall. Smooth muscle hypertrophy may also develop. The Reid index is increased above 0.5 because of enlarged mucus glands. Secondary bacterial infection is common.

These pathological changes result in persistent airflow obstruction and impaired ventilation.

4. What are the clinical consequences of chronic bronchitis?

The hallmark symptom is a chronic productive cough with excessive sputum production. Patients experience progressive dyspnea as airflow obstruction worsens. Wheezing and prolonged expiration are common findings.

Recurrent respiratory tract infections occur because of impaired mucus clearance. Persistent hypoxemia leads to cyanosis and reduced exercise tolerance. Pulmonary hypertension develops due to chronic hypoxic vasoconstriction. Right ventricular hypertrophy and cor pulmonale may occur in advanced disease. Acute exacerbations often require hospitalization.

Respiratory failure may develop during severe exacerbations. Overall quality of life gradually declines without appropriate treatment.

---

 DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 007

 1. What is the difference in clinical presentation between patients with emphysema and those with chronic bronchitis?

Patients with emphysema are typically thin, dyspneic, and maintain near-normal oxygenation until late disease, giving rise to the term "pink puffers." They have severe breathlessness, hyperinflation, and minimal sputum production.

Patients with chronic bronchitis are often overweight with chronic productive cough and abundant sputum. Cyanosis develops early because of hypoxemia, leading to the term "blue bloaters." Pulmonary hypertension and right-sided heart failure occur earlier in chronic bronchitis. Recurrent respiratory infections are more common in chronic bronchitis.

Emphysema primarily involves alveolar destruction, whereas chronic bronchitis mainly affects the bronchi. Many COPD patients show overlapping clinical features. Both conditions progressively impair respiratory function.

2. List the most frequent causes of death in patients with COPD.

Respiratory failure is the leading cause of death in patients with COPD. Acute infective exacerbations commonly precipitate respiratory decompensation. Pulmonary hypertension may progress to cor pulmonale and right-sided heart failure. Severe pneumonia frequently complicates advanced COPD.

Cardiac arrhythmias contribute significantly to mortality. Lung cancer occurs more commonly in smokers with COPD. Pulmonary embolism is another important cause of sudden deterioration. Multiorgan failure may develop during severe exacerbations requiring intensive care.

Chronic hypoxemia increases cardiovascular complications. Early diagnosis, smoking cessation, and optimal treatment reduce mortality.

---

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

 

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS – SSTRSDO-QAA 006

 1. What is emphysema?

Emphysema is a chronic lung disease characterized by permanent enlargement of airspaces distal to the terminal bronchioles with destruction of alveolar walls and minimal fibrosis. It results in loss of elastic recoil and impaired expiration.

Cigarette smoking is the commonest cause. Alpha-1 antitrypsin deficiency causes hereditary emphysema, especially in younger individuals.

Destruction of alveolar septa reduces the surface area available for gas exchange. Small airways collapse during expiration, causing airflow obstruction and air trapping.

The lungs become hyperinflated and less efficient. Patients experience progressive exertional dyspnea. Emphysema is a major component of COPD.

2. What are the main characteristics of different types of emphysema?

The Centriacinar emphysema mainly involves the respiratory bronchioles and predominantly affects the upper lobes. It is strongly associated with cigarette smoking. Panacinar emphysema involves the entire acinus uniformly and mainly affects the lower lobes.

It is commonly associated with alpha-1 antitrypsin deficiency. Distal acinar (paraseptal) emphysema affects the distal acinus near the pleura and interlobular septa. It predisposes to spontaneous pneumothorax in young adults. Irregular emphysema is associated with scarring from previous lung injury.

Centriacinar emphysema is the commonest type encountered clinically. The extent of alveolar destruction determines the severity of respiratory impairment.

3. Describe the main clinical symptoms of emphysema.

                  

Progressive exertional dyspnea is the most prominent symptom of emphysema. Patients often have minimal cough with scanty sputum production. Expiration becomes prolonged because of airflow obstruction. The chest becomes barrel-shaped due to lung hyperinflation. Accessory respiratory muscles are used during breathing. Patients frequently breathe through pursed lips to prevent airway collapse.

Breath sounds are diminished, and wheezing may be present. Weight loss and muscle wasting occur in advanced disease.

Hypoxemia develops late, while carbon dioxide retention appears in severe stages. Respiratory failure may eventually occur.

---

 DR.C.GANESAN M.D

PROFESSOR OF MEDICINE